Detailansicht

Wissensnetz

Person

Florian Schütz (1972-)

Gynäkologe

Name	Florian Schütz
Zeit	1972- (Lebensdaten)
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Gynäkologe (charakteristischer Beruf)
Variante	F. Schütz Florian Schuetz
Weitere Angaben	Oberarzt für Gynäkologie und Geburtshilfe an der Universitätsfrauenklinik Heidelberg
Quelle	Internet
Datensatztyp	Person
GND-Nummer	12303387X
Datensatz-ID	12303387X
Beteiligt an alle anzeigen Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024 Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update Mammakarzinom 2023 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) – Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of Membranes Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023 CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023 Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022 Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021 Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer HER2-targeted therapy influences CTC status in metastatic breast cancer Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer Update Breast Cancer 2020 Part 3 – Early Breast Cancer Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module Exam preparatory course for the 2nd part of the German medical examination in obstetrics and gynecology – a potential tool for the recruitment of new residents during the occupational decision process before the practical year? Prävention und Therapie der Frühgeburt. Leitlinie der DGGG, OEGGG und SGGG (S2k-Niveau, AWMF-Registernummer 015/025, Februar 2019) – Teil 2 mit Empfehlungen zur tertiären Prävention der Frühgeburt und zum Management des frühen vorzeitigen Blasensprungs Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2019 AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019 Update breast cancer 2019 part 1 – implementation of study results of novel study designs in clinical practice in patients with early breast cancer Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers Aufklärungspflichten in der Gynäkologie und Geburtshilfe : Teil 5a: Aufklärungspflichten in der Geburtshilfe – Beratung und Aufklärungspflichten während der Schwangerenbetreuung Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies Erste Hilfe bei Brustkrebs : Universitätsfrauenklinik Heidelberg Erste Hilfe bei Brustkrebs : Universitätsfrauenklinik Heidelberg Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer : guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, December 2017) – part 1 with recommendations for the screening, diagnosis and therapy of breast cancer Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) : Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer Stimulation of chemokines in human endometrial stromal cells by tumor necrosis factor-α and interferon-γ is similar under apoptotic and non-apoptotic conditions Implementation of a novel efficacy score to compare sealing and cutting devices in a porcine model Inter-rater reliability and double reading analysis of an automated three-dimensional breast ultrasound system: comparison of two independent examiners Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Florian Schütz (1972-)

Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update Mammakarzinom 2023 Teil 2 – Brustkrebs in fortgeschrittenen Krankheitsstadien

Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) – Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preterm Premature Rupture of Membranes

Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023

CDK4/6 Inhibitors in Advanced HR+/HER2 – Breast Cancer: A Multicenter Real-World Data Analysis

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2023

Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021

AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer : update 2021

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients

Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer

HER2-targeted therapy influences CTC status in metastatic breast cancer

Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer

Update Breast Cancer 2020 Part 3 – Early Breast Cancer

Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics

Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer

Evaluation of the anti-Thomsen–Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer

Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort

Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score

Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module

Exam preparatory course for the 2nd part of the German medical examination in obstetrics and gynecology – a potential tool for the recruitment of new residents during the occupational decision process before the practical year?

Prävention und Therapie der Frühgeburt. Leitlinie der DGGG, OEGGG und SGGG (S2k-Niveau, AWMF-Registernummer 015/025, Februar 2019) – Teil 2 mit Empfehlungen zur tertiären Prävention der Frühgeburt und zum Management des frühen vorzeitigen Blasensprungs

Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm Birth

Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice

Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer

Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient

AGO recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2019

AGO recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer: Update 2019

Update breast cancer 2019 part 1 – implementation of study results of novel study designs in clinical practice in patients with early breast cancer

Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice

Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade

Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer

RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment

Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers

Aufklärungspflichten in der Gynäkologie und Geburtshilfe : Teil 5a: Aufklärungspflichten in der Geburtshilfe – Beratung und Aufklärungspflichten während der Schwangerenbetreuung

Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies

Erste Hilfe bei Brustkrebs : Universitätsfrauenklinik Heidelberg

Erste Hilfe bei Brustkrebs : Universitätsfrauenklinik Heidelberg

Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer : guideline of the DGGG and the DKG (S3-level, AWMF registry number 032/045OL, December 2017) – part 1 with recommendations for the screening, diagnosis and therapy of breast cancer

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) : Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Stimulation of chemokines in human endometrial stromal cells by tumor necrosis factor-α and interferon-γ is similar under apoptotic and non-apoptotic conditions

Implementation of a novel efficacy score to compare sealing and cutting devices in a porcine model

Inter-rater reliability and double reading analysis of an automated three-dimensional breast ultrasound system: comparison of two independent examiners

Gynecologic oncologists’ attitudes and practices relating to integrative medicine: results of a nationwide AGO survey

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network